v3.26.1
Consolidated Balance Sheets - USD ($)
Mar. 31, 2026
Dec. 31, 2025
Dec. 31, 2024
Assets:      
Cash and cash equivalents $ 2,028,718 $ 5,255,235 $ 38,742
Restricted cash   2,048
Accounts receivable, net 3,336,047 2,687,479 10,353,708
Other receivables   434,391
Prepaid expenses and other current assets 106,934 60,133 99,463
Total current assets 5,471,699 8,002,847 10,928,352
Deposit for acquisition target   2,000,000
Property and equipment, net   20,321
Software development costs, net 4,735,981 4,606,981 4,151,981
Intangible assets, net   25,000
Security deposits   10,351
Goodwill 21,238,450 20,842,508 6,592,304
Investments held in trust account   1,834,540
Total non-current assets 25,974,431 25,449,489 14,634,497
Total assets 31,446,130 33,452,336 25,562,849
Liabilities:      
Bank loan-revolving credit line 2,725,546 2,933,396 3,249,067
Bank loan - current portion   774,095
Loans payable - current portion 669,693 669,693 408,516
Factoring liability 1,566,887 1,511,678
Subordinated convertible promissory notes   3,333,335
Convertible notes 192,897 192,897
Promissory notes 2,500,849 2,499,662 2,486,989
Loans payable - related parties 123,650 123,650 148,088
Accounts payable 1,441,596 1,314,772 1,681,774
Accrued liabilities 4,283,045 4,228,337 2,927,135
Accrued compensation and benefits 1,306,906 919,825 979,684
Accrued interest payable 1,486,041 1,347,787 1,591,023
Excise tax payable 1,167,173 1,167,173 1,157,161
Total current liabilities 17,464,283 16,908,870 18,736,867
Loans payable - non-current portion 300,000 300,000 146,798
Series A Convertible preferred stock ($0.001 par value, 500,000 shares designated, 0 and 345,528 issued and outstanding, respectively)   1,294,117
Total non-current liabilities 300,000 300,000 1,440,915
Total liabilities 17,764,283 17,208,870 20,177,782
Commitments and contingencies (Note 19)
Mezzanine Equity:      
Common Stock subject to possible redemption, $0.0001 par value, 0 and 5,796 shares at redemption value of approximately $11.03 per share, respectively   1,917,309
Stockholders’ Equity:      
Common stock ($0.0001 par value, 300,000,000 shares authorized, 5,510,021 and 3,642,501 shares issued and outstanding, respectively) 551 364 38
Additional paid in capital 46,979,742 46,979,762 6,671,081
Accumulated deficit (29,007,543) (26,879,081) (3,203,361)
Total stockholders’ equity attributable to Cycurion 17,972,765 20,101,060 3,467,758
Deficit attributable to noncontrolling interests (4,290,918) (3,857,594)
Total stockholders’ equity 13,681,847 16,243,466 3,467,758
Total liabilities and stockholders’ equity 31,446,130 33,452,336 25,562,849
Series A Convertible Preferred Stock [Member]      
Stockholders’ Equity:      
Convertible preferred stock
Series B Convertible Preferred Stock [Member]      
Stockholders’ Equity:      
Convertible preferred stock
Series C Convertible Preferred Stock [Member]      
Stockholders’ Equity:      
Convertible preferred stock
Series D Convertible Preferred Stock [Member]      
Stockholders’ Equity:      
Convertible preferred stock 15 15
Series E Convertible Preferred Stock [Member]      
Stockholders’ Equity:      
Convertible preferred stock
Series F Convertible Preferred Stock [Member]      
Stockholders’ Equity:      
Convertible preferred stock
Series G Convertible Preferred Stock [Member]      
Stockholders’ Equity:      
Convertible preferred stock